Characterization of free radicals produced during oxidation of etoposide (VP-16) and its catechol and quinone derivatives. An ESR study
- 1 May 1989
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 28 (11) , 4839-4846
- https://doi.org/10.1021/bi00437a048
Abstract
Spectroscopic evidence for the radical-mediated metabolism of VP-16, VP-16 catechol, and VP-16 quinone during enzymatic oxidation and autoxidation has been obtained. Autoxication of the catechol yields the primary semiquinone together with the primary molecular product VP-16 quinone, which subsequently undergoes hydrolytic oxidation to form secondary quinones and semiquinones. Both primary and secondary phenoxyl radicals were detected during peroxidatic oxidation of VP-16. Neither the primary nor the secondary radicals react with DNA at a detectable rate. Evidence for the production of hydroxyl radical during iron-catalyzed oxidation of VP-16 catechol was obtained. These free radical reactions may have implications for the mechanism of antitumor action of VP-16.This publication has 34 references indexed in Scilit:
- Molecular mechanisms of action of anticancer agents involving free radical intermediatesAdvances in Free Radical Biology & Medicine, 1985
- DNA DAMAGE AS A BASIS FOR 4'-DEMETHYLEPIPODOPHYLLOTOXIN-9-(4,6-O-ETHYLIDENE-BETA-D-GLUCOPYRANOSIDE) (ETOPOSIDE) CYTO-TOXICITY1983
- Electron spin resonance-spin stabilization in enzymatic systems: Detection of semiquinones produced during peroxidatic oxidation of catechols and catecholaminesBiochemical and Biophysical Research Communications, 1982
- Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro.Proceedings of the National Academy of Sciences, 1982
- Inhibition of reverse transcriptase by tyrosinase generated quinones related to levodopa and dopamineChemico-Biological Interactions, 1981
- DNA strand scission by enzymically generated oxygen radicalsArchives of Biochemistry and Biophysics, 1981
- VP 16-213 (VP 16) and cyclophosphamide in the treatment of primitive lung cancer in phase M ICancer, 1979
- Considerations in the spin trapping of superoxide and hydroxyl radical in aqueous systems using 5,5-dimethyl-1-pyrroline-1-oxideBiochemical and Biophysical Research Communications, 1978
- VM 26 and VP 16–213: A comparative analysisCancer, 1977
- Effect of VP-16-213 on the intracellular degradation of DNA in HeLa cellsBiochemistry, 1976